8 Comments
Sep 7, 2022Liked by Partnership Investing

I very agree with your conclusions, I see it as a possible portfolio guardian at the appropriate multiples and waiting a possible expansion at other markets.

Expand full comment
author

Exactly, great company to own at the right price. Hope to see developments around capital allocation and growth.

Expand full comment
Sep 2, 2022Liked by Partnership Investing

If I look at the employee split, they have 1/4 of total people in the US...mostly sales.

How can they possibly be more agressive in that area?

Expand full comment
author

US is 1/3 of the total market, the most profitable market and the most difficult to penetrate. I think this warrants a larger presence to grow the installed base faster.

How could they be more aggressive? Simply hiring more sales employees. What would growth look like if they had 30 or 35 sales reps instead of 25?

Expand full comment

Have you had a chance to ask them about putting more weight behind US expansion?

Expand full comment
author

Haven't asked mgmt directly, but I have spoken with some people that indicated reinvestment in general is being discussed and mgmt is open to it. No specifics though.

Its a Board decision anyways, so mgmt only can do it if Board decides to prioritize reinvestment over dividend.

Expand full comment
Sep 2, 2022Liked by Partnership Investing

Thanks a lot again! I also had Medistim on my radar but it didnt Flash me enough. Would appreciate an analysis for Eurofins :)

Expand full comment

-17% today 🧐

Expand full comment